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Quantitative studies of the mortality impact of past inﬂuenza
pandemics are important to inform pandemic preparedness efforts but are hampered by a paucity of historical data sets and
substantial heterogeneity in the experience of individual countries [1]. Much has been written about the devastating 1918
pandemic, as well as the recent 2009 pandemic. However, the
1957 and 1968 pandemics have received considerably less attention [2–4]. In particular, no quantitative global mortality estimates are available for the 1957 and 1968 pandemics, even
though both pandemics inform preparedness efforts for moderate severity pandemics [5]. The relationship between economic
development and pandemic-related mortality rates appears
moderate for the 1918 pandemic [2] and weaker for the 2009
pandemic [3], but the strength of the relationship remains uncertain for other pandemics.
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Here we focus on the 1957 pandemic, for which multicountry
comparative epidemiological studies are lacking. Much of the
world experienced sustained pandemic inﬂuenza A(H2N2) virus
transmission by December 1957, with recurrent waves of pandemic activity occurring over several years [6, 7]. Quantitative
studies of excess mortality associated with the 1957 inﬂuenza pandemic have been limited to a few economically developed countries, including the United States, Canada, England and Wales,
Germany, and Singapore [7–9], with age-speciﬁc estimates available for the United States and Canada only [6, 7, 10]. No information is available from Latin America, Africa, the Middle East, or
Eastern Europe. Here we used a detailed World health Organization (WHO) mortality database to infer the mortality burden of
the 1957 inﬂuenza pandemic in 39 countries with adequate data.
We modeled the relationship between country-speciﬁc development indicators and pandemic mortality and extrapolated this relationship to estimate the global burden of the 1957 pandemic.
MATERIAL AND METHODS
Data Sources

WHO Mortality Data

We compiled annual age- and cause-speciﬁc mortality statistics
from the WHO Cause of Death Query Online database [11],
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Background. Quantitative estimates of the global burden of the 1957 inﬂuenza pandemic are lacking. Here we ﬁll this gap by
modeling historical mortality statistics.
Methods. We used annual rates of age- and cause-speciﬁc deaths to estimate pandemic-related mortality in excess of background
levels in 39 countries in Europe, the Asia-Paciﬁc region, and the Americas. We modeled the relationship between excess mortality
and development indicators to extrapolate the global burden of the pandemic.
Results. The pandemic-associated excess respiratory mortality rate was 1.9/10 000 population (95% conﬁdence interval [CI],
1.2–2.6 cases/10 000 population) on average during 1957–1959. Excess mortality rates varied 70-fold across countries; Europe
and Latin America experienced the lowest and highest rates, respectively. Excess mortality was delayed by 1–2 years in 18 countries
(46%). Increases in the mortality rate relative to baseline were greatest in school-aged children and young adults, with no evidence
that elderly population was spared from excess mortality. Development indicators were moderate predictors of excess mortality, explaining 35%–77% of the variance. Overall, we attribute 1.1 million excess deaths (95% CI, .7 million–1.5 million excess deaths)
globally to the 1957–1959 pandemic.
Conclusions. The global mortality rate of the 1957–1959 inﬂuenza pandemic was moderate relative to that of the 1918 pandemic
but was approximately 10-fold greater than that of the 2009 pandemic. The impact of the pandemic on mortality was delayed in
several countries, pointing to a window of opportunity for vaccination in a future pandemic.
Keywords. mortality rates; pandemic inﬂuenza; historical studies; vital statistics; severity; models; global disease burden;
development indicators; health indicators; pandemic planning.

Indicators of Development

We queried Gapminder [12] to compile country-speciﬁc gross
domestic product (GDP) and gross national income estimates
for 1960–1975 and infant mortality rates for 1950–1970. Data
were available for 122 countries, including the 46 countries in
our mortality data set, representing 82% of the world population. Development indicators were interpolated by spline for
unavailable years; we used estimates for 1957 for comparison
with inﬂuenza mortality estimates. Baseline cause-speciﬁc mortality rates (available for countries providing data to the WHO
database [11]) were also considered as indicators of development.
Statistical Analysis

We adapted a so-called excess-mortality approach previously developed to estimate the global burden of the 1918 pandemic on
the basis of annual mortality data [2]. Because mortality rates
showed marked time trends during the 1950s in most countries,
we ﬁt spline functions to annual mortality time series to infer baseline mortality. Separate models were ﬁtted to each country, cause of
death (all-cause death, death due to respiratory diseases, and death
due to pneumonia and inﬂuenza), and age group (Supplementary
Figures 1 and 2). Pandemic years 1957–1959 were excluded from
baseline calculations; we also excluded 1951 for the United Kingdom, Ireland, and Canada, which coincided with the occurrence of
an unusually severe inﬂuenza season that resulted in substantial increase in mortality due to respiratory causes [8]. Pandemic-related
excess mortality was estimated as the observed mortality in 1957
minus the modeled baseline mortality. We also assessed the occurrence of second and third pandemic-associated waves of excess
mortality in 1958 and 1959. We also tabulated the proportion of
excess deaths occurring in each age group and the elevation
above the baseline level during the 3-year pandemic period.
To explore the association between pandemic excess mortality rates and indicators of development, we ﬁt univariate and

multivariate linear regression models with excess mortality
rates as the outcome and development indicators as covariates,
separately by age group and death outcome.
To extrapolate the global burden of the pandemic, we applied
the regression model developed for countries with available vital
statistics data (39 countries for respiratory and cardiorespiratory
disease outcomes and 46 countries for pneumonia and inﬂuenza outcomes) to the larger sample of 122 countries in our data
set, using socioeconomic and health indicators as predictors.
We generated 95% conﬁdence intervals (CIs) by bootstrap.
RESULTS
Pandemic-Associated Rates of Excess Mortality Due to Respiratory
Diseases

Our main analysis focused on estimates of pandemic-related
excess mortality in 1957 and during 1957–1959 for 39 countries
reporting deaths due to respiratory diseases. There was a >70fold difference in pandemic-associated excess respiratory mortality rates in 1957 between countries, ranging from no measurable impact in Egypt to 5.5 deaths/10 000 population in Chile
(Figure 1, Table 1, and Supplementary Table 2). The 10 countries with lowest excess mortality included European countries
and Egypt, whereas the 5 countries with highest excess mortality
included Latin American countries and Finland. Cumulative excess pandemic mortality rates for the 1957–1959 period ranged
from 0.3 deaths/10 000 population (Egypt) to 9.8 deaths/10 000
population (Chile), a 30-fold difference. Of the 39 countries,
the impact on excess mortality in 18 (44%) was delayed to the
second or third year of pandemic virus circulation. In Europe
and Australia in particular, the majority of inﬂuenza-related
deaths occurred in the third year of pandemic inﬂuenza A
(H2N2) virus activity (Supplementary Table 2).
Age-speciﬁc excess mortality rates were highest at both extremes of the age spectrum (Table 2). However, when excess
mortality was compared to baseline mortality rates, the age
groups with highest relative burden were 15–24 years (34% elevation over baseline mortality levels for the 3-year period of
1957–1959), followed by 5–14 years (27% increase over baseline;
Figure 1 and Table 2). In contrast, children aged <5 years and seniors aged ≥65 years only experienced a minor elevation over
baseline (8%; Table 2). The sharp mortality elevation in schoolaged children and young adults was consistent throughout Europe
(Figure 1), even though the all-age impact of the pandemic on
mortality was generally low in this region.
Relationship With Development Indicators

Development indicators such as GDP, infant mortality rates, baseline respiratory death rates, and latitude were weakly associated
with pandemic-related excess mortality rates due to respiratory
diseases in univariate analyses, explaining 6%–35% of differences
between countries (P < .006; Table 3). Stepwise multivariate regression indicated that GDP was the sole predictor of cumulative
excess mortality due to respiratory diseases during 1957–1959,
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selecting all countries that had data for 1955–1965 or longer.
Choice of this minimum study period allowed for ﬁtting nonpandemic mortality baseline values and capturing potential recrudescent pandemic waves throughout 1957–1959, while remaining
inclusive. We used the International Classiﬁcation of Diseases, Seventh Revision, to tabulate deaths with underlying causes coded as
pneumonia and inﬂuenza, respiratory diseases, and respiratory
and cardiac diseases (disease codes are available in Supplementary
Table 1). Our main analysis was based on respiratory deaths,
available for 39 countries, while sensitivity analyses were based
on deaths from respiratory and cardiac causes (a more sensitive
outcome available for 39 countries) and pneumonia and inﬂuenza
(a more speciﬁc outcome available for 46 countries).
Deaths counts were tabulated for 7 age groups (0–4, 5–14,
15–24, 25–49, 50–64, ≥65 years, and all ages). Annual agespeciﬁc population data were obtained from the same WHO
database [11]; population estimates for missing years were interpolated by thin-plate smoothing splines.

Downloaded from http://jid.oxfordjournals.org/ at GWU on February 24, 2016

Figure 1. Country-specific influenza-related excess mortality rates from respiratory causes, 1950–1970. Excess mortality rate is calculated as the observed annual mortality
rate minus a model-predicted spline baseline fitted to the mortality rate outside the 1957–1959 pandemic period. The 2 black vertical lines highlight mortality attributable to the
pandemic period. A, All-age mortality. B, Mortality among individuals aged 15–24 years, the age group with the highest increase in mortality, relative to baseline, during the
pandemic period. Mortality rates range from low (yellow) to high (red). Abbreviation: SAR, Special Administrative Region.
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Table 1. Global Pandemic Influenza Mortality Burden Estimates for 1957
and for the 3-Year Period 1957–1959
Pandemic-Related Excess
Mortality, Deaths/10 000
Population (95% CI)
Mortality Outcome and Model

Table 3. Identified Predictors of Pandemic-Related Excess Mortality
Burden During 1957–1959 for Each Mortality Outcome Under Study

Outcome, Predictor
Death due to
pneumonia and
influenza

1957

1957–1959

Deaths due to pneumonia and influenzab

1.2 (.8–1.6)

1.8 (1.3–2.6)

Baseline death rate

Deaths due respiratory diseasesc

1.3 (.8–1.9)

1.9 (1.3–2.9)

Deaths due cardiorespiratory diseasesc

1.5 (.9–2.1)

2.4 (1.8–3.0)

Death due to
respiratory diseases

Population-weighted mean for select countriesa

Countries,
No.

% Variance
Explained
R2

46

45

39

38

Deaths due to pneumonia and influenza

1.7 (1.3–2.2)

2.9 (2.1–3.8)

Deaths due respiratory diseases

2.3 (1.6–2.9)

4.0 (2.6–5.3)

Deaths due cardiorespiratory diseases

2.4 (1.6–3.1)

4.0 (2.8–5.1)

Abbreviations: CI, confidence interval; ICD-7, International Classification of Diseases,
Seventh Revision.

0.36 ± 0.06

<.0001

−0.170 ± 0.126

Latitude
Death due to
cardiorespiratory
diseases

P
Values

−0.00315 ± 0.001

GDP

Global extrapolationd

Point
Estimate ± SE

39

.0037
.19

37

GDP

−0.00257 ± 0.001

.016

−0.255 ± 0.127

.053

Latitude

a

Regression model outcomes are deaths/10 000 population for all ages combined. Predictors
are selected by stepwise regression and based on countries with adequately detailed
mortality data.

b

Data are for 46 countries, using ICD-7A or ICD-7B codes.

Abbreviations: GDP, gross domestic product; SE, standard error.

c

Data are for 39 countries, using ICD-7A codes.

d

Pandemic mortality rates were extrapolated to 122 countries, using the observed
relationship between country-specific mortality estimates and development indicators.
Data are based on a multivariate model including gross domestic product and latitude as
predictors; 95% CIs rely on bootstrapping. See Supplementary Table 2 for country-specific
mortality estimates.

explaining 28% of the variance, while GDP and latitude explained
43% of the variance in excess mortality during 1957. Standardizing burden estimates by baseline respiratory death rates reduced
but did not eliminate differences between countries.
On the basis of the modeled relationship between excess
mortality rates due to respiratory diseases, GDP, and latitude,
we extrapolated the pandemic burden to 122 countries with
available information on development indicators (Table 1 and
Figure 2). We estimate a global excess mortality rate of 4.0
deaths/10 000 population (95% CI, 2.6–5.3 deaths/10 000 population) during 1957–1959, corresponding to 1.1 million excess
Table 2.

Sensitivity Analysis Using Different Disease Outcomes

Similar geographic differences and pandemic predictors were
obtained in analyses of mortality due to pneumonia and inﬂuenza, a more speciﬁc outcome that was available for a larger

Age-Specific Estimates of the Global Pandemic-Related Mortality Burden

Age Group, y
0–4

deaths (95% CI, .7 million–1.5 million excess deaths) due to respiratory diseases in the 1957 world population.
Predictors of pandemic-related mortality varied with age.
Predictors included infant mortality for children aged <5
years, GDP for seniors, and baseline respiratory mortality for
intermediate age groups (this factor alone explained 87%–99%
of the variance). The global excess respiratory mortality rate
extrapolated from age-speciﬁc data was 5.2 deaths/10 000 population (95% CI, 3.3–7.4 deaths/10 000 population) for the
1957–1959 pandemic period (Table 2). Two-thirds of pandemicrelated deaths were among individuals <65 years of age.

Excess Respiratory Deaths/10 000
Population, Mean of
39 Countries (95% CI)a
10.44 (5.16–16.48)

RR of PandemicRelated Death,
Mean (95% CI)a,b

Global Extrapolation of Excess,
Deaths/10 000 Population,
Mean (95% CI)c

0.08 (.06–.11)

15.99 (10.19–21.82)

Global Extrapolation of
the no. of Excess Deaths,
Mean ± SDc
659 700 ± 119 900

Age Group–Specific
Excess Deaths,
% of Total
44.1

5–14

0.63 (.48–.81)

0.27 (.21–.35)

0.93 (.71–1.15)

61 900 ± 7400

4.1

15–24

0.55 (.42–.73)

0.34 (.26–.42)

0.89 (.46–1.47)

40 100 ± 11 300

2.7

25–49

0.67 (.48–.97)

0.16 (.13–.19)

1.12 (.64–1.67)

94 500 ± 21 700

6.3

50–64

3.17 (2.39–4.32)

0.13 (.11–.17)

5.46 (3.68–7.48)

155 000 ± 26 900

10.3

≥65
Overall

12.93 (8.5–19.6)

0.08 (.05–.13)

23.3 (14.43–34.66)

3.43 (2.1–5.06)

0.14 (.06–.32)

5.23 (3.31–7.4)

486 300 ± 105 500

32.5

1 488 500 ± 272 000

100.0

All estimates represent cumulative excess deaths due to respiratory diseases during the 1957–1959 pandemic period.
Abbreviation: CI, confidence interval.
a

Estimates are for 39 countries with adequately detailed vital statistics data.

b

Relative risk (RR) is calculated as the excess respiratory disease–associated mortality rate in 1957–1959 divided by the baseline mortality rate during 1957–1959. This ratio considers severity in
an age group or a country as a relative measure and adjusts for different levels of background mortality.

c

Data are estimates extrapolated to 122 countries, using separate models based on development indicators fitted to each age group.
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Estimates are for countries with adequately detailed vital statistics data in the World Health
Organization mortality database. Estimates of pandemic-related excess mortality rates are
based on the difference between the observed mortality rate during pandemic years and
a model-predicted spline baseline rate fitted to the mortality rate in the surrounding years.

sample of 46 countries (Table 1). There was a >25-fold difference
in pandemic-related excess mortality rates due to pneumonia
and inﬂuenza during 1957–1959 between countries, and baseline mortality was the only consistent predictor in multivariate
analyses of all age and age-speciﬁc data (P < .02). The bottom
10 countries for excess mortality included Europe, the United
States, Israel, and Egypt, while the top excess mortality rates
were found in Latin American countries, with Chile faring
the worst, in line with our main analysis. Extrapolation indicated a global excess mortality rate due to pneumonia and inﬂuenza of 2.9 deaths/10 000 population (95% CI, 2.1–3.8
deaths/10 000 population) during 1957–1959, thus capturing
73% of our global estimate based on the broader respiratory
death outcome (Table 1).
Analysis of cardiorespiratory deaths, a more sensitive mortality outcome available in 39 countries, provided results nearly
identical to those of deaths due to respiratory diseases in
742

•

JID 2016:213 (1 March)

•

Viboud et al

terms of excess mortality predictors and global extrapolations
(Tables 1 and 3). Across all analyses, the average pandemicrelated excess mortality rates in the countries with available
vital statistics data were 30%–50% lower than our global extrapolations based on regression models applied to 122 world countries (Table 1).
DISCUSSION

To our knowledge, this is the ﬁrst study to generate global mortality estimates for the 1957 pandemic that are grounded in
analysis of mortality data from multiple countries. We used
WHO mortality databases to generate estimates and explore between-country variation in pandemic burden in a diverse set of
regions. Infection with pandemic inﬂuenza A(H2N2) virus was
associated with 4.0 excess deaths due to respiratory diseases per
10 000 population (95% CI, 2.6–5.3 deaths/10 000 population) over the ﬁrst 3 years of circulation, during 1957–1959,

Downloaded from http://jid.oxfordjournals.org/ at GWU on February 24, 2016

Figure 2. Global maps of pandemic influenza–related mortality rates during the 1957–1959 pandemic period. Estimates are based on 39 countries with available respiratory
disease–related mortality data (top panel) and model extrapolation to 122 world countries based on development and geographic indicators (bottom panel).

We also considered other potential sources of increased mortality related to natural disasters and military unrest as a potential source of mismeasurement. We identiﬁed 6 events relevant
to our study period, including 4 military coups (in Colombia,
Venezuela, El Salvador, and Panama), a war (in Egypt), and
an earthquake (in Chile). Five of these events did not result in
elevated cause-speciﬁc mortality (mortality due to cardiorespiratory and respiratory diseases in years coinciding with these
events were either below or within 5% of baseline). The 6th
notable event relates to a military coup in Venezuela in 1958,
coinciding with a 19% mortality elevation over baseline. However, mortality rates were even higher in 1957, the ﬁrst year of
the pandemic, and remained elevated in 1959, the third year of
pandemic virus circulation, suggesting that the observed mortality elevation is part of a long-lasting pandemic effect rather
than due to civil unrest. Further substantiation of this argument
is provided by the age patterns of deaths in Venezuela, as the
increase in mortality during 1958 was most pronounced in
the 5–24-year age group and most attenuated in other age
groups, as would be expected if such elevation were caused by
the pandemic.
Overall, despite uncertainty in some of our lower end estimates, our large multinational sample convincingly indicates
that Latin America—and particularly Chile—fared substantially
worse than other regions. Further, the full range of global extrapolations provided in this study by use of different approaches
should be considered as plausible estimates of the 1957–1959
pandemic burden (0.7 million–2.1 million excess deaths, corresponding to mortality rates of 2.6–7.4 deaths/10 000 population).
Our country-level analysis revealed great (25–70-fold) geographic variation in the pandemic-related mortality burden, explained in part by health and economic disparities (with the
latter explaining 37%–99% of variance for various mortality
outcomes). A multinational study of the 1918 pandemic reported 30-fold variation in excess mortality rates across 27 countries; approximately 50% of the variance could be attributed
to differences in income, but health indicators such as infant
mortality or respiratory death rates were not studied [2].
Substantial residual variation in mortality remained in our
study after adjustment for development indicators, including
among neighboring countries. For example, Finland experienced substantially higher mortality than Denmark, the Netherlands, or Sweden. In addition, the extremely low impact of
pandemic-related mortality in Egypt is notable; however, the
lack of additional mortality data from the region precludes further comparison. Owing to the lack of relevant vital statistics
data, our global model extrapolated to 122 countries did not include potentially important health covariates, such as background respiratory mortality rates. In this study, we have
shown that background cause-speciﬁc mortality can be an important predictor of the pandemic-related mortality burden, especially for highly speciﬁc outcomes, such as pneumonia and
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corresponding to 1.1 million deaths globally (95% CI, .7 million–
1.5 million deaths). Of the countries with available vital statistics data, we found a 25–70-fold variation in excess mortality
rate estimates for the pandemic period of 1957–1959, depending on the cause of death considered, with even morepronounced variation in the ﬁrst year of pandemic virus
circulation. Development indicators such as GDP, infant
mortality, and baseline respiratory mortality rates, as well as
latitude, were moderate predictors of excess mortality rates.
Interestingly, the brunt of pandemic’s impact was delayed to
the second and third year of pandemic virus circulation in
44% of countries with WHO data.
Traditional inﬂuenza-associated excess mortality studies have
relied on seasonal regression of weekly or monthly mortality statistics, but such data are lacking for the period relevant to the
1957–1959 pandemic for most countries. Instead, we used an annualized approach adapted from a study of the 1918 pandemic
[2], in which we estimated annual mortality occurring in excess
of a ﬂexible model baseline value ﬁtted to surrounding years. Unlike the previous study [2], however, we considered cause-speciﬁc
deaths, including those due to pneumonia and inﬂuenza, respiratory diseases, and cardiorespiratory diseases, rather than all-cause
mortality, which increases the speciﬁcity of our estimates.
We checked the validity of our approach for Chile, the United
States, and Canada, where both annual and monthly vital statistics were available [6, 7, 10, 13]. Reassuringly, estimates for Chile
were highly consistent between the annualized approach and
traditional seasonal regression methods relying on temporally
disaggregated data [13]. For Canada and the United States,
our estimates for the ﬁrst wave of the 1957 pandemic, based
on annual all-age data, were substantially lower than those reported earlier, although age-speciﬁc estimates were more consistent, especially for individuals aged <65 years [6, 7, 10].
This is due in part to the relatively mild nature of this pandemic
in the United States and Canada and to the preponderance of
age groups with high baseline mortality levels in aggregated
all-age data, particularly those involving infants and elderly individuals [6–8, 14]. This so-called drowning effect may explain
why global extrapolations based on age-speciﬁc data were consistently higher than those based on all-age data, suggesting that
age-speciﬁc extrapolations may be more valid.
Another limitation of our annual approach is that we cannot
remove the effect of seasonal inﬂuenza epidemics from the
baseline, except for the unusual occurrence of well-characterized severe inﬂuenza seasons, such as the 1951 epidemic in
the United Kingdom, Ireland, and Canada [8]. Similarly, we
cannot remove the effect of unusual outbreaks of other respiratory pathogens in baseline calculations. Overall, our pandemic
estimates measure the amount of excess mortality occurring
above and beyond that of typical seasons, which include the
combined effect of many pathogens, and hence these estimates
should be regarded as conservative.
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countries, including several countries (such as Chile) with a
GDP of less than $2000/year. Our global extrapolation model
infers high pandemic-related excess mortality rates in lowincome countries underrepresented in our sample, which drives
global estimates upward. This explains why our globally extrapolated pandemic rates are 33%–50% higher than the average excess mortality rate estimated for countries with historical data.
Our study covered a broad geographic scope, including the
Americas, Europe, and the Asia-Paciﬁc region; however, we
did not have any data from Africa. As in other international inﬂuenza studies [2, 3], the paucity of available data from Africa
indicates that global estimates may not be fully representative of
the global pandemic experience.
The age patterns of the 1957 pandemic have been well described in the United States and Canada [7, 16] and align well
with our ﬁndings in a larger set of countries. We found a sharp
elevation of excess mortality rates among school-aged groups at
the time of the pandemic, with a consistent signature even in
countries mildly affected by the pandemic overall. The impact
on school-aged children was particularly pronounced in the
ﬁrst year of inﬂuenza A(H2N2) virus circulation, while the impact on older adults was stronger in subsequent years—a pattern reminiscent of the 1918 and 2009 pandemic [17–19].
Excess mortality rates were lowest in school-aged children
and increased monotonously at older ages, in line with agespeciﬁc excess mortality rates reported in the United States [7, 16]
and consistent with a lack of protection of the elderly population from excess mortality (termed “senior sparing”). A seroepidemiology study has reported prepandemic protective
antibodies to A/H2 in Dutch persons older than approximately
70 years [20] and is not necessarily contradictory to our data, as
it would have been nearly impossible to detect a sparing effect,
given the small population size of these age groups and the resolution of our data set. It is generally accepted that senior sparing did not play a major role in the 1957 pandemic, in contrast
to the 1918, 1968, and 2009 pandemics, when seniors were partially protected due to prior childhood exposure to antigenically
related viruses [3, 17, 21–24].
In conclusion, our study ﬁlls a gap in the availability of global
mortality estimates for historical inﬂuenza pandemics, which
can help guide pandemic planning. Our model extrapolates
2.7 million inﬂuenza-related deaths (95% CI, 1.6 million–3.4
million deaths) should a virus of similar severity to the 1957
pandemic inﬂuenza A(H2N2) virus return in the 2005 population, which is intermediate between global estimates for the
2009 pandemic (0.3 million–0.4 million deaths [3]) and a devastating 1918-like pandemic (62 million deaths; range, 51 million–81 million deaths [2]). Overall, our study reinforces
substantial geographic variation in the pandemic-related mortality burden between countries, much of which remains unexplained, thus echoing recent work on the 1918 and 2009
pandemic [2, 3]. Such variations indicate that the proposed
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inﬂuenza. Moving forward, accurate projection of the disease
burden of future pandemic events would require availability
of these covariates for a large sample of countries.
Between-country variation could be attributed in part to differences in prior immunity, as prior experience with inﬂuenza
A(H1N1) virus may have reduced the severity of inﬂuenza
A(H2N2) virus infection, although the mechanisms of crosssubtypic immunity remain debated [15]. It is worth noting that
a severe epidemic of inﬂuenza A(H1N1) infection swept through
the United Kingdom, the northeastern United States, and Canada in 1951 [8] and featured as a season with a high mortality
rate in some of the studied countries. Although information on
global inﬂuenza virus strain circulation is scarce prior to 1957,
heterogeneity in exposure to inﬂuenza A(H1N1) virus could
have affected baseline immunity to the 1957 pandemic virus.
Alternatively, seasons of severe inﬂuenza A(H1N1) virus infection could have resulted in the death of frail individuals prior to
the emergence of the pandemic inﬂuenza A(H2N2) virus in
some regions.
Our regression models indicate that mortality predictors varied by age and mortality outcome. In particular, baseline mortality rates were strong predictors of pandemic-related excess
mortality due to pneumonia and inﬂuenza, while GDP was a better predictor of broader disease outcomes. The infant mortality
rate was a strong predictor of pandemic-related excess mortality
in children <5 years of age, perhaps because infant mortality is a
fair indicator of infectious diseases–related health issues in younger age groups. Interestingly, high GDP was predictive of high excess mortality among seniors, perhaps because a higher GDP
correlates with a greater share of older age groups demographically and greater prevalence of comorbid conditions. Overall, estimates for the youngest and oldest segments of the population
have to be taken with caution because of the use of an annual approach and the high background death rate of these age groups
[14]. In contrast, mortality estimates for intermediate age groups
are more speciﬁc and robust, especially for teenagers and young
adults, who were particularly affected by this pandemic.
Geographic variation in excess mortality rates was reduced by
standardizing burden estimates by baseline rates of death, suggesting that underlying coding practices may affect disease estimates. In particular, Chile was a clear outlier in the magnitude
of mortality due to pneumonia and inﬂuenza and to respiratory
diseases, even in prepandemic seasons, with 2–3-fold higher
baseline rates than Colombia. Such a large difference could in
principle reﬂect a higher propensity of doctors to assign deaths
to respiratory illnesses in Chile; however, the magnitude of
pandemic-related estimates of mortality due to cardiorespiratory diseases in this country indicates this is not simply a coding
artifact.
The sample of countries contributing historical vital statistics
data to the WHO was biased toward highly developed regions,
although we did have fair representation of low-income

use of a pandemic severity index may be problematic unless it is
based on multiple countries representative of a spectrum of
health and economic development in several world regions.
Further, our study suggests that it is critical to both consider
the absolute and relative impact of a pandemic—by country
and age groups—to fully understand severity patterns in various
populations. In future pandemics, it will be critical to analyze
severity statistics from a number of indicator countries, to generate more-accurate estimates of the global disease burden in
near real time.
Supplementary Data
Supplementary materials are available at http://jid.oxfordjournals.org.
Consisting of data provided by the author to beneﬁt the reader, the posted
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